EE456 Cost-Effectiveness of Tenofovir Alafenamide (TAF) for Treatment of Chronic Hepatitis B in Taiwan
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.701
https://www.valueinhealthjournal.com/article/S1098-3015(22)02905-9/fulltext
Title :
EE456 Cost-Effectiveness of Tenofovir Alafenamide (TAF) for Treatment of Chronic Hepatitis B in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02905-9&doi=10.1016/j.jval.2022.09.701
First page :
Section Title :
Open access? :
No
Section Order :
10238